D-0390-2019 Class II Terminated

Recalled by LUPIN SOMERSET — Somerset, NJ

FDA drug recall D-0390-2019 was initiated by LUPIN SOMERSET on Jan 15, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative… The recall status is terminated (terminated Feb 17, 2023). Affected quantity: 24,180 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 30, 2019
Initiation Date
Jan 15, 2019
Termination Date
Feb 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,180 bottles

Product description

Fluocinolone Acetonide Topical Solution, USP, 0.01 %, 60 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; NDC 43386-069-60.

Reason for recall

Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #: S700214, Exp Apr-19; S700447, Exp Jun-19; S700787, Exp Oct-19; S701057, Exp Nov-19; S800107, Exp Feb-20; S800266, Exp Mar-20; S800524, Exp May-20; S800791, Exp Jul-20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0390-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0390-2019. Report a data issue: hello@regdatalab.com.